RxDoctor Payments Data

Anna Cook

Family · Chocowinity, NCNPI 1548837636

Payments from drug & device makers

$532in general payments, 2019–2025

Across 30 payments — averaging $17.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$131
  • GSK$69
  • AstraZeneca$68
  • Amgen$61
  • Novo Nordisk$52
  • Corcept Therapeutics$37
  • plus $115 from 5 others

What the payments were for

  • Food & beverage$532100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$532 in reported general payments places this provider in the 55th percentile of 4,522 family providers in North Carolina.

See all family providers in North Carolina

Medicare billing

Part B allowed, 2024
$39,537
Medicare patients
171
Services billed
967

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin42$38,023
FarxigaDapagliflozin Propanediol26$14,986
MyrbetriqMirabegron20$13,407
OzempicSemaglutide13$12,385
EliquisApixaban16$12,147
LinzessLinaclotide12$6,532
LantusInsulin Glargine,hum.Rec.Anlog14$2,190
Lantus SolostarInsulin Glargine,hum.Rec.Anlog22$1,960
Omeprazole134$1,877
Atorvastatin Calcium187$1,798
Pravastatin Sodium105$1,719
Losartan Potassium166$1,497
Amlodipine Besylate252$1,464
Gabapentin98$1,314
Levothyroxine Sodium144$1,281

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$14$38,02342 claims
AstraZenecaFarxiga$68$14,98626 claims
Novo NordiskOzempic$52$12,38513 claims
PfizerEliquis$35$12,14716 claims
AbbVieLinzess$30$6,53212 claims
Lilly USA, LLCInsulin Lispro$131$83711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 4,522 family providers in North Carolina.

Other family in Chocowinity

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →